论文部分内容阅读
目的研究脑梗塞血脂异常与高同型半胱氨酸血症的相关性。方法选择了2014年1月-2015年12月入我院治疗的急性脑梗塞患者100例,依据血脂检测结果将其分为观察组和对照组,每组50例。其中观察组患者血脂正常,对照组患者血脂异常,对比两组高同型半胱氨酸血症发生率。结果通过对比分析,对照组患者发生高同型半胱氨酸血症的几率明显高于观察组,其中观察组发生率为51.00%,对照组为86.21%,两组差异显著,具有统计学意义(P<0.05)。对照组急性脑梗塞复发率显著高于观察组,其中对照组复发率为73.11%,观察组复发率为33.00%,两组差异显著,具有统计学意义(P<0.05)。结论急性脑梗塞血脂异常患者发生高同型半胱氨酸血症的几率显著增高,且急性脑梗塞的复发几率显著增加。因此针对急性脑梗塞血脂异常患者,应当积极预防、治疗高同型半胱氨酸血症的发生、发展。
Objective To study the relationship between cerebral infarction dyslipidemia and hyperhomocysteinemia. Methods One hundred patients with acute cerebral infarction who were treated in our hospital from January 2014 to December 2015 were selected and divided into observation group and control group according to the result of blood lipid test, 50 cases in each group. The observation group patients with normal blood lipids, the control group patients with dyslipidemia, compared with two high homocysteine incidence. Results By comparative analysis, the incidence of hyperhomocysteinemia in the control group was significantly higher than that in the observation group (51.00% in the observation group and 86.21% in the control group), with significant difference between the two groups P <0.05). The recurrence rate of acute cerebral infarction in the control group was significantly higher than that in the observation group. The recurrence rate was 73.11% in the control group and 33.00% in the observation group. There was significant difference between the two groups (P <0.05). Conclusion The incidence of hyperhomocysteinemia in patients with acute cerebral infarction dyslipidemia is significantly increased, and the risk of recurrent acute cerebral infarction is significantly increased. Therefore, for patients with acute cerebral infarction dyslipidemia, should actively prevent and treat high homocysteine in the occurrence and development.